Polycystic ovary syndrome - PubMed (original) (raw)

Review

Polycystic ovary syndrome

Ricardo Azziz et al. Nat Rev Dis Primers. 2016.

Abstract

Polycystic ovary syndrome (PCOS) affects 5-20% of women of reproductive age worldwide. The condition is characterized by hyperandrogenism, ovulatory dysfunction and polycystic ovarian morphology (PCOM) - with excessive androgen production by the ovaries being a key feature of PCOS. Metabolic dysfunction characterized by insulin resistance and compensatory hyperinsulinaemia is evident in the vast majority of affected individuals. PCOS increases the risk for type 2 diabetes mellitus, gestational diabetes and other pregnancy-related complications, venous thromboembolism, cerebrovascular and cardiovascular events and endometrial cancer. PCOS is a diagnosis of exclusion, based primarily on the presence of hyperandrogenism, ovulatory dysfunction and PCOM. Treatment should be tailored to the complaints and needs of the patient and involves targeting metabolic abnormalities through lifestyle changes, medication and potentially surgery for the prevention and management of excess weight, androgen suppression and/or blockade, endometrial protection, reproductive therapy and the detection and treatment of psychological features. This Primer summarizes the current state of knowledge regarding the epidemiology, mechanisms and pathophysiology, diagnosis, screening and prevention, management and future investigational directions of the disorder.

PubMed Disclaimer

Similar articles

• Polycystic ovary syndrome and acne.
  Chuan SS, Chang RJ. Chuan SS, et al. Skin Therapy Lett. 2010 Nov-Dec;15(10):1-4. Skin Therapy Lett. 2010. PMID: 21076799
• Current concepts of polycystic ovary syndrome.
  Rosenfield RL. Rosenfield RL. Baillieres Clin Obstet Gynaecol. 1997 Jun;11(2):307-33. doi: 10.1016/s0950-3552(97)80039-9. Baillieres Clin Obstet Gynaecol. 1997. PMID: 9536213 Review.
• Polycystic ovary syndrome: a review for dermatologists: Part I. Diagnosis and manifestations.
  Housman E, Reynolds RV. Housman E, et al. J Am Acad Dermatol. 2014 Nov;71(5):847.e1-847.e10; quiz 857-8. doi: 10.1016/j.jaad.2014.05.007. Epub 2014 Oct 15. J Am Acad Dermatol. 2014. PMID: 25437977 Review.
• Polycystic Ovary Syndrome.
  Azziz R. Azziz R. Obstet Gynecol. 2018 Aug;132(2):321-336. doi: 10.1097/AOG.0000000000002698. Obstet Gynecol. 2018. PMID: 29995717 Review.
• Polycystic ovary syndrome: a dermatologic approach.
  Moura HH, Costa DL, Bagatin E, Sodré CT, Manela-Azulay M. Moura HH, et al. An Bras Dermatol. 2011 Jan-Feb;86(1):111-9. doi: 10.1590/s0365-05962011000100015. An Bras Dermatol. 2011. PMID: 21437531 Review. English, Portuguese.

Cited by

• The association of CYP11A1 gene polymorphisms with the polycystic ovary syndrome patients.
  Alyousif SSH, Ozbakir B, Ozay AC, Tulay P. Alyousif SSH, et al. Rev Assoc Med Bras (1992). 2024 Jul 19;70(7):e20231293. doi: 10.1590/1806-9282.20231293. eCollection 2024. Rev Assoc Med Bras (1992). 2024. PMID: 39045925 Free PMC article.
• Does moxonidine reduce Achilles tendon or musculoskeletal pain in women with polycystic ovarian syndrome? A secondary analysis of a randomised controlled trial.
  Jewson J, Lambert E, Sari C, Jona E, Shorakae S, Lambert G, Gaida J. Jewson J, et al. BMC Endocr Disord. 2020 Aug 26;20(1):131. doi: 10.1186/s12902-020-00610-8. BMC Endocr Disord. 2020. PMID: 32847570 Free PMC article. Clinical Trial.
• Therapeutic Effects of Silibinin Against Polycystic Ovary Syndrome Induced by Letrozole in Rats via Its Potential Anti-Inflammatory and Anti-Oxidant Activities.
  Marouf BH, Ismaeel DO, Hassan AH, Ali OJ. Marouf BH, et al. J Inflamm Res. 2022 Sep 9;15:5185-5199. doi: 10.2147/JIR.S379725. eCollection 2022. J Inflamm Res. 2022. PMID: 36110507 Free PMC article.
• Tumor Necrosis Factor Alpha Level in the Uterine Fluid of Patients with Polycystic Ovary Syndrome and Its Correlation with Clinical Parameters.
  Ha LX, Li WX, Du YD, Yuan YY, Qu XX. Ha LX, et al. J Inflamm Res. 2022 Oct 29;15:6015-6020. doi: 10.2147/JIR.S382808. eCollection 2022. J Inflamm Res. 2022. PMID: 36339827 Free PMC article.
• Hypertension Risk in Young Women With Polycystic Ovary Syndrome: A Nationwide Population-Based Cohort Study.
  Wu CH, Chiu LT, Chang YJ, Lee CI, Lee MS, Lee TH, Wei JC. Wu CH, et al. Front Med (Lausanne). 2020 Sep 23;7:574651. doi: 10.3389/fmed.2020.574651. eCollection 2020. Front Med (Lausanne). 2020. PMID: 33072787 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database
  • scite Smart Citations

• Medical

  • MedlinePlus Health Information